Showing results (11-20 of 145) with videos related to
Sort By:
Pageof 15
Mini Reviews in Medicinal Chemistry|April 20, 2012
Angiogenesis as a therapeutic target in breast cancerAngelos K Koutras, Ioannis Starakis, Dionysia Lymperatou, et al.Critical Reviews in Oncology/Hematology|July 8, 2008
Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapiesAndreas A Argyriou, Anna Antonacopoulou, Gregoris Iconomou, et al.Journal of Pain and Symptom Management|May 31, 2011
Epothilone-induced peripheral neuropathy: a review of current knowledgeAndreas A Argyriou, Paola Marmiroli, Guido Cavaletti, et al.Cancer Management and Research|March 28, 2014
Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literatureAndreas A Argyriou, Athanasios P Kyritsis, Thomas Makatsoris, et al.Gene|May 14, 2013
Alternative splicing generates a truncated isoform of human TNFRSF11A (RANK) with an altered capacity to activate NF-κBChaido Sirinian, Anastasios D Papanastasiou, Ioannis K Zarkadis, et al.Anticancer Research|July 11, 2006
Capecitabine-induced hypertriglyceridemia: a report of two casesAngelos K Koutras, Ioannis G Habeos, Apostolos G Vagenakis, et al.Cancer Treatment Reviews|November 26, 2009
Bevacizumab in the treatment of breast cancerAngelos K Koutras, George Fountzilas, Thomas Makatsoris, et al.Anticancer Research|January 25, 2008
Brain metastasis in renal cell cancer responding to sunitinibAngelos K Koutras, Dimitrios Krikelis, Natassa Alexandrou, et al.Cancer Chemotherapy and Pharmacology|August 30, 2008
Dual targeting of EGFR and HER-2 in colon cancer cell linesEfstathia Giannopoulou, Anna Antonacopoulou, Konstantina Floratou, et al.Critical Reviews in Oncology/Hematology|March 11, 2008
Peripheral nerve damage associated with administration of taxanes in patients with cancerAndreas A Argyriou, Martin Koltzenburg, Panagiotis Polychronopoulos, et al.Pageof 15